Radiation Oncology/Therapy: Page 44

Siemens, MD Anderson create MRI for rad therapy program

By AuntMinnie.com staff writers

Siemens Healthineers and the University of Texas MD Anderson Cancer Center have developed a global education program to enable consistent implementation of MRI in radiation oncology.

September 28, 2021

New interventional oncology guidelines will boost research

By Kate Madden Yee

New guidelines for interventional oncology will increase research on image-guided procedures and standardize patient care, according to a report published September 28 in Radiology.

September 27, 2021

ASTRO urges members to oppose Medicare payment cuts

By AuntMinnie.com staff writers

The American Society for Radiation Oncology (ASTRO) is urging its members to contact their representatives in the U.S. Congress to scale back cuts proposed by Medicare in reimbursement for radiation oncology services.

September 26, 2021

Blue Earth highlights new Axumin research

By AuntMinnie.com staff writers

Bracco molecular imaging subsidiary Blue Earth Diagnostics is directing attention to new research that found PET/CT imaging with its Axumin PET radiopharmaceutical had a significant impact on management of patients with recurrent prostate cancer.

September 26, 2021

Theragnostics enters licensing deal with AAA for Ga-68 PET

By AuntMinnie.com staff writers

Theragnostics has signed a global licensing agreement with Advanced Accelerator Applications (AAA) to develop and commercialize gallium-68 (Ga-68) one-step PET radiopharmaceuticals.

September 21, 2021

SNMMI updates appropriate use criteria for PSMA PET

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released new guidance for the clinical use of prostate-specific membrane antigen (PSMA)-PET imaging.

September 20, 2021

Radiation therapy for breast cancer boosts risk of heart disease

By Amerigo Allegretto

Women who undergo radiation therapy to the left side of the chest to treat breast cancer are at twice the risk for coronary artery disease, according to research published September 21 in the Journal of the American College of Cardiology.

September 20, 2021

BWXT and Bayer to focus on therapeutic radionuclides

By AuntMinnie.com staff writers

BWXT Medical and Bayer have entered an agreement to ramp up their supply of actinium-225 as both companies seek to broaden commercialization strategies for targeted radionuclide therapies.

September 15, 2021

IBA, SCK CEN sign actinium-225 deal

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) and Belgian nuclear research center SCK CEN have partnered to enable the production of the medical radioisotope actinium-225.

September 14, 2021

Accuray promotes prostate cancer research at ESTRO 2021

By AuntMinnie.com staff writers

Radiation oncology firm Accuray is highlighting research presented at the recent European Society for Radiotherapy and Oncology (ESTRO) annual congress on the benefits of its CyberKnife robotic radiotherapy platform in prostate cancer treatment.

September 13, 2021

Lantheus, RefleXion to collaborate on prostate cancer treatment

By AuntMinnie.com staff writers

Lantheus Medical Imaging parent Lantheus Holdings and radiation therapy equipment developer RefleXion Medical have signed a development and marketing partnership to evaluate the use of Lantheus' prostate-specific membrane antigen-targeted PET agent piflufolastat F-18 with RefleXion's X1 biology-guided radiotherapy system.

September 12, 2021

B dot Medical unveils scanning magnet for proton therapy

By AuntMinnie.com staff writers

B dot Medical has manufactured a scanning magnet for a compact proton therapy system currently under development.

September 9, 2021

Previous Page

Page 44 of 464

Next Page